Linaclotide Acetate

Linaclotide Acetate is a cyclic tetradecapeptide made by chemical synthesis, structurally analogous to endogenous guanylin and uroguanylin within human gastrointestinal tissue. This peptide compound acts as a highly selective Guanylate Cyclase‑C (GC‑C) agonist that delivers pharmacological benefits locally inside intestinal lumen with negligible systemic uptake after oral exposure.

Once linaclotide acetate contacts intestinal epithelial luminal receptors, both parent peptide and its biologically‑active metabolite bind specifically to GC‑C sites. Such receptor activation raises cGMP concentration on both intracellular and extracellular sides of epithelium. Elevated intracellular cGMP triggers CFTR ion‑channel opening, promoting chloride and bicarbonate efflux into gut cavity. Extra intestinal fluid softens stool and accelerates whole gastrointestinal transit. Meanwhile, extracellular cGMP suppresses visceral nociceptive nerve signaling to ease abdominal bloating and gut‑related discomfort.

Because almost no ingredient enters blood circulation, linaclotide acetate exerts gut‑restricted pharmacology and avoids widespread off‑target systemic effects. Our supplied material is white‑to‑off‑white amorphous peptide powder, offered in medical‑grade and peptide‑research‑grade batches for API development and laboratory investigation only. Sealed cold storage at ‑20℃ away from light and moisture guarantees full 2‑year shelf‑life of finished powder lots.

Linaclotide effectiveness

1.effective symptom relief: linaclotide works locally in the intestines to reduce pain and discomfort while promoting regular bowel movements.

2.dual action mechanism: it increases fluid secretion in the intestines and accelerates transit time, addressing both constipation and abdominal pain.

3.minimal systemic absorption: linaclotide acts primarily in the gut, ensuring targeted treatment with fewer systemic side effects.

4.clinically proven: extensive studies have demonstrated linaclotide's effectiveness in improving bowel habits and reducing abdominal pain in IBS-C and CIC patients.

Linaclotide uses and application areas

1.irritable bowel syndrome with constipation (IBS-C): reduces abdominal pain, bloating, and constipation.

2.chronic idiopathic constipation (CIC): promotes regular bowel movements in patients with persistent constipation of unknown cause.

1. Absorption Characteristics: Minimal systemic absorption after oral intake; undetectable in blood circulation within 3-5 hours, low systemic side effect risk.
2. Adverse Reaction Profile: The most common mild adverse reaction is slight diarrhea (incidence ≤20%), usually occurring within 2 weeks of administration, dose-dependent and self-relieving. Occasional rare reactions include mild nausea and flatulence, no severe organ toxicity reported.
3. Contraindications: Strictly prohibited for children under 2 years old; avoid use in 2-18 years old group due to dehydration risk. Not recommended for pregnant and lactating women without clinical safety data support.
4. Toxicity Level: Classified as WGK 3 in Germany; oral acute toxicity Class 4, non-highly toxic raw material.
5. Stability & Safety: Stable under sealed -20℃ storage; no degradation or harmful substance precipitation within 2-year shelf life.

• Rigorous Batch‑wise Quality Assurance Every production lot undergoes complete HPLC profiling. We strictly enforce ≥98% purity baseline. Each shipment comes with full COA, HPLC chromatogram spectrum and related testing documentation for your lab record or registration submission.
• Flexible Pack‑size Supply Chain We cover small lab sample quantity (100mg,1g), pilot‑test batch (100g), up to commercial bulk kilogram orders. Custom impurity‑profile requirements are acceptable for pharma clients.
• Global Multi‑mode Logistics Support DHL / UPS / FedEx air courier, sea freight and air‑cargo options available. Goods get dispatched within 24 working hours once payment confirmed, covering door‑to‑door and port‑to‑port delivery solutions worldwide.
• Complete Compliance Document Kit MSDS, third‑party independent lab test reports and customs‑oriented certificates are ready to assist cross‑border clearance and your product registration workflows.
• Specialized Peptide Technical Assistance Our in‑house peptide R&D team offers mechanism consultation, solubility guidance, storage handling tips and after‑sales technical follow‑up for biotech and pharmaceutical partners.
• Stable Long‑term Bulk Inventory Large on‑site raw‑material stock maintains consistent delivery rhythm. Long‑term framework supply contracts can be signed for global biotech and pharma enterprises.

We deliver one‑stop OEM & custom service tailored to linaclotide acetate peptide project requirements for research institutes and pharma customers:

• Custom Synthesis & Purification Adjustment Support fine‑tuning purification process for higher purity demand, custom salt‑form processing, custom impurity‑control threshold according to your project protocol.
• Customized Packaging Service Custom inner/outer labeling, custom unit‑pack specifications from mg‑level sample vial, aluminium foil bag to 1kg / 25kg drum bulk packaging. Custom label text compliant with export regulation.
• Batch‑specific Document Customization Adjust COA format, generate project‑targeted test‑report versions to satisfy internal lab management or regulatory submission requirements.
• Scale‑up Manufacturing Service Support technology transfer from lab gram‑scale trial to pilot‑plant kilogram‑level production. We assist process optimization for your future commercial API development.
• Confidentiality Commitment Strict non‑disclosure agreement for all OEM / custom projects; customer project data and formula information will never be shared with third‑party organizations.

Send inquiry or contact us to get free sample, and learn more details about it.

Send Inquiry Now

Hot Tags: Linaclotide Acetate, China Linaclotide Acetate manufacturers, suppliers, factory